Payments to doctors in Australia are to be scrutinised after marketing tactics are exposed
BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6714 (Published 18 October 2011) Cite this as: BMJ 2011;343:d6714- Ray Moynihan
- 1Byron Bay, Australia
The Australian Medical Association has said it is to review its policies on disclosure after a former drug industry insider spoke openly on a radio programme about how “doctors are being used to sell drugs to patients.”
The review will look specifically at whether doctors’ payments from companies should be disclosed to patients, said Steve Hambleton, the association’s president.
Brendan Shaw, chief executive of the industry body Medicines Australia, also said that greater transparency would be considered as part of a review of the industry’s self regulatory code of conduct.
Petra Helesic, who marketed drugs for more than a …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.